Login to Your Account



Columbia Plunges Following Adcomm Meeting on Prochieve

By Mari Serebrov
Washington Editor

Monday, January 23, 2012
Columbia Laboratories Inc. fought a losing battle Friday in a statistical throwdown with the FDA at an advisory committee meeting convened to consider whether data from the PREGNANT trial are enough to support a preterm birth indication for Columbia's Prochieve (progesterone gel 8 percent).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription